In the last several years, there has been no agreement on how to possibly expand the Milan criteria (MC) in the selection of patients with hepatocellular carcinoma (HCC) for listing for liver transplant (LT). The aim of the study is to evaluate morphological and biological tumor parameters to identify new expanded criteria for the selection of patients with HCC as candidates for LT.

Lai, Q., Avolio, A. W., Manzia, T., Sorge, R., Agnes, S., Tisone, G., Berloco, P., Rossi, M., Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation, <<CLINICAL TRANSPLANTATION>>, 2012; 26 (2): E125-E125-31. [doi:10.1111/j.1399-0012.2011.01572.x] [http://hdl.handle.net/10807/40456]

Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation

Avolio, Alfonso Wolfango;Agnes, Salvatore;
2012

Abstract

In the last several years, there has been no agreement on how to possibly expand the Milan criteria (MC) in the selection of patients with hepatocellular carcinoma (HCC) for listing for liver transplant (LT). The aim of the study is to evaluate morphological and biological tumor parameters to identify new expanded criteria for the selection of patients with HCC as candidates for LT.
2012
Inglese
Lai, Q., Avolio, A. W., Manzia, T., Sorge, R., Agnes, S., Tisone, G., Berloco, P., Rossi, M., Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation, <<CLINICAL TRANSPLANTATION>>, 2012; 26 (2): E125-E125-31. [doi:10.1111/j.1399-0012.2011.01572.x] [http://hdl.handle.net/10807/40456]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/40456
Citazioni
  • ???jsp.display-item.citation.pmc??? 29
  • Scopus 61
  • ???jsp.display-item.citation.isi??? 58
social impact